title: mTOR inhibitors as primary immunosuppression after heart transplant: confounding factors in clinical trials.
authors.affiliation: Cardiac Transplant and VAD Program, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
authors.forename: S S
authors.initials: SS
authors.lastname: Kushwaha
mesh_terms: D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007677:Kidney Function Tests; D008297:Male; D020123:Sirolimus / Q000008:administration & dosage*
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus